Further, combining CSFR1 inhibition with PD-1/PD-L1 blocking antibodies resulted in superior tumor control compared to checkpoint inhibition alone in a mouse model of spontaneous neuroblastoma82. The gene discussed is CD274; the disease is neoplasm.